In a 28-page written submission to the UK’s Competition and Markets Authority (CMA) that was published Monday, January 10, the semiconductor heavyweights Nvidia, Softbank, and Arm outlined why their deal should be approved, reported CNBC.
The deal, which is set to miss the target deadline of March 2022, is being closely scrutinized by regulators in the US, the UK, Europe, and China, who are concerned that it could reduce competition. SoftBank, Nvidia, and Arm agreed to complete the transaction within 18 months of September 2020.
There’s a high chance that one or more of the regulators will block the deal altogether, according to Gartner analyst Alan Priestley and other investors.
Related: FTC Sues To Block Nvidia’s $40B Deal For UK’s Arm
Widely viewed as a the jewel in the crown of the UK tech industry, Arm was spun out of an early computing company called Acorn Computers in 1990. The company’s energy-efficient chip designs are used in 95% of the world’s smartphones and 95% of the chips designed in China. The company, bought by SoftBank in 2016 for £24 billion (US$32 billion), licenses its chip designs to more than 500 companies who use them to make their own semiconductors.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI